Table 4.
Perinatal and neonatal outcomes of study groups
| Perinatal and neonatal outcomes | Severe Preeclampsia (n=903) | Eclampsia (n=123) | HELLP syndrome (n=196) | P |
|---|---|---|---|---|
| Admission to ICU, % | 14.8 | 21.6 | 17.3 | 0.169a |
| Duration of ICU (d, median, Q1–Q3) | 13.5 (6–23.7) | 8 (3.2–26.7) | 15 (9–32.5) | 0.345a |
| RDS, % | 13.2 | 19.5 | 16.0 | 0.169* |
| IVH grades 3 and 4, % | 1.3 | 2.7 | 2.6 | 0.379* |
| NEC grades 2 and 3, % | 4.1 | 4.4 | 7.7 | 0.159* |
| Sepsis, % | 6.7 | 6.2 | 8.3 | 0.735* |
| Duration of hospitalization (d, median, Q1–Q3) | 4 (2–12) | 4 (3–15) | 6 (3–15) | 0.0001a P1b 0.025 P2b 0.0001 P3b 0.182 |
| Perinatal mortality, % | 13.1 | 7.7 | 13.7 | 0.231* |
| ≤32 weeks, % | 36.5 | 15.4 | 36.4 | 0.034* |
| >32 weeks, % | 4.9 | 3.8 | 3.3 | 0.706* |
| Neonatal mortality, % | 5.6 | 4.6 | 5.9 | 0.890* |
| ≤32 weeks, % | 21 | 11.4 | 21.6 | 0.415* |
| >32 weeks, % | 1.7 | 1.4 | 0.9 | 0.815* |
| >28 days mortality, % | 1.1 | 1.9 | 4.8 | 0.009* |
a
According to Kruskal–Wallis test (triple comparison) P<0.05
b
Mann-Whitney U test P1=Severe Preeclampsia versus Eclampsia, P2= Severe preeclampsia versus HELLP Syndrome, P3=Eclampsia versus HELLP Syndrome. Significant p value after Bonferroni correction <0.017
*
According to χ2 test for trend